Index of medicine substances

N-acetyl aspartyl glutamic acid  •  Sensory organs | Decongestants and antiallergics | Other antiallergics (S01GX03)

Nadroparin  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Heparin group (B01AB06)

Naftidrofuryl  •  Cardiovascular system | Peripheral vasodilators | Peripheral vasodilators | Other peripheral vasodilators (C04AX21)

Nalbuphine  •  Nervous system | Opioids | Morphinan derivatives (N02AF02)

Naldemedine  •  Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Peripheral opioid receptor antagonists (A06AH05)

Nalidixic acid  •  Antiinfectives for systemic use | Quinolone antibacterials | Other quinolones (J01MB02)

Nalmefen  •  Nervous system | Drugs used in addictive disorders | Drugs used in alcohol dependence (N07BB)

Nalorphine  •  Various | All other therapeutic products | All other therapeutic products | Antidotes (V03AB02)

Naloxegol  •  Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Peripheral opioid receptor antagonists (A06AH03)

Naloxone  •  Various | All other therapeutic products | All other therapeutic products | Antidotes (V03AB15)

Naltrexone  •  Nervous system | Drugs used in addictive disorders | Drugs used in alcohol dependence (N07BB04)

Naltrexone + bupropion  •  Alimentary tract and metabolism | Antiobesity preparations, excl. diet products | Centrally acting antiobesity products (A08AA62)

Nandrolone  •  Sensory organs | Other ophthalmologicals (S01XA11)

Nanocolloidal human albumin  •  Various | Hepatic and reticulo endothelial system | Technetium (99mtc), particles and colloids (V09DB01)

Naphazoline  •  Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants (S01GA01)

Naphazoline + chlorpheniramine maleate  •  Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants (S01GA51)

Naphazoline + neomycin + dexamethasone  •  Respiratory system | Decongestants and other nasal preparations for topical use | Sympathomimetics, combinations excl. corticosteroids (R01AB05)

Naphazoline + pheniramine maleate  •  Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants (S01GA51)

Naphtifine  •  Dermatologicals | Antifungals for topical use | Other antifungals for topical use (D01AE22)

Naproxen  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives (M01AE02)

Naproxen + esomeprazole  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Propionic acid derivatives (M01AE52)

Naratriptan  •  Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists (N02CC02)

Natalizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA23)

Natamycin  •  Dermatologicals | Antifungals for topical use | Antibiotics (D01AA02)

Natamycin + neomycin + hydrocortisone  •  Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, weak, combinations with antibiotics (D07CA01)

Nateglinide  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Other blood glucose lowering drugs, excl. insulins (A10BX03)

Natural alfa interferon  •  Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Interferons (L03AB01)

Nebivolol  •  Cardiovascular system | Beta blocking agents | Beta blocking agents | Beta blocking agents, selective (C07AB12)

Nebivolol + amlodipine  •  Cardiovascular system | Beta blocking agents | Beta blocking agents, other combinations | Beta blocking agents and calcium channel blockers (C07FB12)

Nebivolol + hydrochlorothiazide  •  Cardiovascular system | Beta blocking agents | Beta blocking agents and thiazides | Beta blocking agents, selective, and thiazides (C07BB12)